Related Experiment Videos
Update on newborn screening for cystic fibrosis
Jeffrey S Wagener1, Marci K Sontag, Scott D Sagel
1University of Colorado Medical School, Department of Pediatrics, Denver, Colorado, USA. wagener.jeff@tchden.org
Current Opinion in Pulmonary Medicine
|October 29, 2004
Summary
Newborn screening for cystic fibrosis (CF) offers significant health benefits, including improved nutrition and cognitive potential. While definitive proof of reduced lung disease or prolonged survival is pending, the consensus supports early detection for CF patients.
Area of Science:
- Medical Genetics
- Pediatric Health
- Public Health Screening
Background:
- Cystic Fibrosis (CF) is a prevalent lethal genetic disorder diagnosed in childhood in the US.
- Newborn screening for CF has increased, leading to early diagnosis and management.
- An expert panel convened in 2003 to review CF newborn screening indications.
Purpose of the Study:
- To review information and publications regarding the indications for CF newborn screening.
- To discuss the benefits and challenges associated with CF newborn screening.
- To assess the current consensus on the value of CF newborn screening.
Main Methods:
- Review of existing literature and data leading up to and following the 2003 expert panel meeting.
- Analysis of health and psychosocial outcomes in infants diagnosed with CF via newborn screening.
- Evaluation of the general consensus on the benefits of CF newborn screening.
Main Results:
- Newborn screening leads to improved nutrition and avoidance of complications for CF patients.
- Early identification facilitates specialized care in CF centers, necessitating infection risk management.
- Psychosocial benefits include reduced diagnostic stress and family planning support, alongside challenges like carrier identification.
Conclusions:
- While reduced lung disease and prolonged survival are not definitively proven, improved nutrition and cognitive potential are recognized benefits.
- Screening leads to reduced hospitalization and intensive therapy costs.
- The general consensus supports the benefits of newborn screening for cystic fibrosis.